With its inception on May 21, 2000, Lifecare Innovations Pvt. Ltd. has proved out as a renowned manufacturer of several life saving drugs. The company has ensured the availability of effective, secure and affordable drug Liposomal Amphotericin B. It has been engaged in manufacturing, research, development, marketing and supplying of the useful healthcare products. It was incorporated to address the unmet requirements of medical field, with the latest innovative technologies and new age formulations. The pharmaceuticals are employing array of technologies in novel drug delivery system. These generic drugs are effective against numerous ailments, which are caused due to useless bacteria in the body.
The use of drugs destroys existing bacteria and restricts the formation of more harmful bacteria inside the human body. We offer wide range of drugs and antibacterial products to our customers. We, as a reputed distributor of life saving drugs, produced pills for Kala Azar and Fungal Infections. Amphotericin B was found the effective cure for diseases like Kala Azar but later, due to toxicity has been formulated to FUNGISOMETM. It is the most appropriate, affordable and easy solution to severe illness. Pharmaceutical drugs are always suggested to be taken under proper medication or the prescription by physicians.
Amphotericin B is a broad spectrum and potent antifungal among all drugs discovered in the last century. It does not reflected any drug resistance and thus possess a paradoxical status. FUNGISOMETM is developed by formulating Amphotericin, and is commonly known drug for all kind of fungal infections. We are professionally directed rapidly growly company among the pharmaceutical spectrum spread across the globe. We aim to provide quality health care to all stratum of the society. Thus, we are a life saving drug manufacturing company in Gurgaon, aiming to target the unmet requirements of pharma and medical fields. If you any queries or would like to develop long term partnership with us, feel free to contact us.
0 comments:
Post a Comment